NasdaqCM - Delayed Quote USD

Tonix Pharmaceuticals Holding Corp. (TNXP)

0.1600 +0.0032 (+2.04%)
At close: April 24 at 4:00 PM EDT
0.1609 +0.00 (+0.56%)
After hours: April 24 at 7:33 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
7,768.0000
7,768.0000
--
--
--
Cost of Revenue
4,741.0000
4,741.0000
--
--
--
Gross Profit
3,027.0000
3,027.0000
--
--
--
Operating Expense
121,407.0000
121,407.0000
112,091.0000
92,312.0000
50,511.0000
Operating Income
-118,380.0000
-118,380.0000
-112,091.0000
-92,312.0000
-50,511.0000
Net Non Operating Interest Income Expense
751.0000
--
1,873.0000
25.0000
48.0000
Other Income Expense
1,722.0000
1,722.0000
1,873.0000
--
--
Pretax Income
-116,658.0000
-116,658.0000
-110,218.0000
-92,287.0000
-50,463.0000
Net Income Common Stockholders
-116,658.0000
-116,658.0000
-116,877.0000
-92,287.0000
-52,174.0000
Diluted NI Available to Com Stockholders
-116,658.0000
-116,658.0000
-116,877.0000
-92,287.0000
-52,174.0000
Basic EPS
-6.85
--
-20.01
-50.62
-110.00
Diluted EPS
-6.85
--
-20.01
-50.62
-110.00
Basic Average Shares
17,039.3090
--
5,841.4470
1,821.9690
472.9580
Diluted Average Shares
17,039.3090
--
5,841.4470
1,821.9690
472.9580
Total Operating Income as Reported
-118,380.0000
-118,380.0000
-112,091.0000
-92,312.0000
-50,511.0000
Total Expenses
126,148.0000
126,148.0000
112,091.0000
92,312.0000
50,511.0000
Interest Income
751.0000
--
1,873.0000
25.0000
48.0000
Net Interest Income
751.0000
--
1,873.0000
25.0000
48.0000
Net Income from Continuing & Discontinued Operation
-116,658.0000
-116,658.0000
-110,218.0000
-92,287.0000
-50,463.0000
Normalized Income
-116,658.0000
-116,658.0000
-110,218.0000
-92,287.0000
-50,463.0000
EBIT
-118,380.0000
-118,380.0000
-112,091.0000
-92,312.0000
-50,511.0000
EBITDA
-114,089.0000
-114,089.0000
-110,838.0000
-92,262.0000
-50,484.0000
Reconciled Cost of Revenue
4,741.0000
4,741.0000
--
--
--
Reconciled Depreciation
4,291.0000
4,291.0000
1,253.0000
50.0000
27.0000
Net Income from Continuing Operation Net Minority Interest
-116,658.0000
-116,658.0000
-110,218.0000
-92,287.0000
-50,463.0000
Normalized EBITDA
-114,089.0000
-114,089.0000
-110,838.0000
-92,262.0000
-50,484.0000
12/31/2020 - 5/10/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

JAGX Jaguar Health, Inc.
0.1699
+1.13%
 
IBIO iBio, Inc.
1.9000
0.00%
 
ALLK Allakos Inc.
1.0200
-2.86%
 
AGEN Agenus Inc.
7.42
+14.86%
 
NBY NovaBay Pharmaceuticals, Inc.
0.0773
+0.39%
 
RNAZ TransCode Therapeutics, Inc.
0.4399
-4.35%
 
TCON TRACON Pharmaceuticals, Inc.
1.8900
+2.16%
 
VBIV VBI Vaccines Inc.
0.5900
-3.04%
 
OCGN Ocugen, Inc.
1.1800
-5.60%
 
VXRT Vaxart, Inc.
0.7097
-4.79%